CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,105,191 | -34.5% | 1,625,943 | 0.0% | 13.24% | -1.8% |
| Q2 2023 | $16,942,326 | +49.5% | 1,625,943 | 0.0% | 13.48% | +34.8% |
| Q1 2023 | $11,332,823 | +15.6% | 1,625,943 | 0.0% | 10.01% | +32.5% |
| Q4 2022 | $9,804,436 | -27.4% | 1,625,943 | -4.9% | 7.56% | -29.2% |
| Q3 2022 | $13,500,000 | -42.1% | 1,709,781 | 0.0% | 10.67% | -40.4% |
| Q2 2022 | $23,300,000 | -30.4% | 1,709,781 | 0.0% | 17.91% | -0.6% |
| Q1 2022 | $33,500,000 | -68.9% | 1,709,781 | -45.5% | 18.01% | -44.8% |
| Q4 2021 | $107,600,000 | -37.1% | 3,134,780 | 0.0% | 32.65% | -34.9% |
| Q3 2021 | $171,200,000 | -25.6% | 3,134,780 | 0.0% | 50.12% | +41.8% |
| Q2 2021 | $230,000,000 | -19.8% | 3,134,780 | 0.0% | 35.34% | -24.7% |
| Q1 2021 | $286,707,000 | +12.9% | 3,134,780 | 0.0% | 46.92% | -19.1% |
| Q4 2020 | $254,000,000 | – | 3,134,780 | – | 58.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |